GAO: FDA fails to follow up on unproven drugs
Sunday, October 25, 2009 - 23:42
in Health & Medicine
WASHINGTON (AP) -- The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn't extend patients' lives, say congressional investigators....